Skip to main content
. 2016 Jul 21;26(2):291–298. doi: 10.1007/s11136-016-1369-4

Table 2.

Demographic data for focus group participants

Group 1
(n = 7)
Group 2
(n = 8)
Group 3
(n = 8)
Group 4
(n = 6)
Overall 1–4
(n = 29)
Female (no.) 5 5 7 6 23
Duration RA, years mean (IQR) 8 15.4 16.7 9 12.3 (4–10)
Erosive disease (no.) 1 4 4 4 13
Medication
 DMARD use (no.) 7 7 7 5 26
 Biological use (no.) 2 6 3 3 14
Age, years (mean, SD) 57.5 56.1 58.7 55.2 56.8 (8.9)
VAS fatigue 0–100 (mean, SD) 67 (12.8)
HAQ, 0–3 (mean, SD) 1.1 (0.6)
RADAI, 0–10 (mean, SD) 2.7 (1.8)